We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SILC:NASDAQSilicom Ltd Analysis

Data as of 2026-05-27 - not real-time

$47.06

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Silicom Ltd. (SILC) is trading at $47.06, comfortably above its 20‑day, 50‑day and 200‑day moving averages of $43.57, $31.56 and $20.46 respectively, indicating a strong bullish bias. The RSI sits at 63.9, leaving room for upside before overbought conditions, while the MACD histogram is slightly negative, hinting at a short‑term pull‑back. Volatility is exceptionally high at 127% over the past 30 days and beta is 1.61, underscoring pronounced price swings and market sensitivity. Fundamentally, the company posted a 33% year‑over‑year revenue increase to $66.6 M, but continues to operate at a loss with operating margin of –14.7% and negative EPS, while holding $35 M in cash against $6.6 M of debt.
Recent material news highlights a "mega" order that accelerated revenue growth, a $5 M/year design win with a Tier‑1 cyber‑security leader, and adoption of Silicom’s AI inference acceleration solution, all of which could fuel top‑line expansion. However, the lack of profitability, high leverage (debt‑to‑equity 5.69), and zero dividend support a cautious outlook despite the positive momentum.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above all major moving averages
  • MACD bearish divergence suggesting near‑term pullback
  • High short‑term volatility and beta

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • 33% revenue growth driven by large design wins
  • Strong cash position relative to modest debt
  • Strategic AI and cyber‑security product adoption expanding addressable market

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Persistent operating losses and negative margins
  • Potential for profitability if growth initiatives materialize
  • Elevated valuation metrics for a loss‑making company

Key Metrics & Analysis

Financial Health

Revenue Growth32.80%
Profit Margin-16.57%
P/E Ratio-102.3
ROE-9.17%
ROA-4.80%
Debt/Equity5.69
P/B Ratio2.3
Industry P/E40.4

Technical Analysis

TrendBullish
RSI63.9
Support$27.10
Resistance$52.58
MA 20$43.57
MA 50$31.56
MA 200$20.46
MACDBearish
VolumeStable
Fear & Greed Index92.34

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.61
Volatility127.61%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.